diseas
sinc
spread
rapidli
around
world
case
current
report
countri
five
contin
diseas
featur
give
rise
great
concern
includ
poorli
understood
epidemiolog
pathogenesi
absenc
definit
diagnost
test
specif
treatment
incub
period
allow
rapid
spread
along
intern
airtravel
rout
incomplet
understood
pattern
nosocomi
transmiss
mount
evid
certain
sourc
case
make
special
contribut
rapid
spread
infect
disturb
concentr
case
previous
healthi
hospit
staff
initi
case
fatal
initi
unclear
causal
agent
develop
emerg
plan
contain
outbreak
prevent
intern
spread
work
principl
unidentifi
causal
agent
could
lead
except
danger
outbreak
rapid
develop
scientif
knowledg
would
need
reduc
opportun
sar
establish
endem
identif
causal
agent
develop
diagnost
test
given
paramount
import
overal
contain
strategi
view
epidemiologist
virologist
long
causal
agent
remain
unknown
specif
intervent
agent
avail
specialist
infecti
diseas
control
would
forc
resort
control
tool
isol
quarantin
member
global
influenza
surveil
network
nation
influenza
centr
countri
four
collabor
centr
alreadi
increas
vigil
novel
influenza
viru
report
receiv
earli
februari
guangdong
provinc
china
case
five
death
caus
atyp
pneumonia
unknown
caus
laboratori
analys
influenza
virus
report
neg
feb
influenza
network
activ
emerg
pandem
respons
plan
receiv
report
depart
health
hong
kong
confirm
presenc
avian
influenza
viru
subtyp
boy
age
year
whose
famili
travel
fujian
provinc
china
januari
laboratori
influenza
network
rule
influenza
viru
strain
known
caus
pneumonia
sampl
taken
hanoi
singapor
hong
kong
sar
look
increasingli
like
new
diseas
epidemiolog
evid
suggest
persontoperson
transmiss
major
rout
caus
agent
maintain
pathogen
transmiss
sar
could
becom
first
sever
new
diseas
centuri
global
epidem
potenti
except
aid
new
diseas
emerg
past
two
decad
establish
endem
new
geograph
area
featur
limit
capac
pose
major
threat
intern
public
health
exampl
avian
influenza
nipah
viru
hendra
viru
hanta
viru
establish
effici
humantohuman
transmiss
diseas
escherichia
coli
variant
creutzfeldtjakob
diseas
depend
food
vehicl
transmiss
diseas
west
nile
fever
rift
valley
fever
spread
new
geograph
area
requir
vector
part
transmiss
cycl
associ
low
mortal
although
frequent
occur
highrisk
group
elderli
immunocompromis
peopl
comorbid
still
other
neisseria
meningitidi
ebola
marburg
crimeancongo
haemorrhag
fever
strong
geograph
foci
although
outbreak
ebola
haemorrhag
fever
associ
case
fatal
uganda
democrat
republ
congo
persontoperson
transmiss
requir
close
physic
exposur
infect
blood
bodili
fluid
sever
acut
respiratori
syndrom
new
diseas
human
be
first
recognis
late
februari
hanoi
vietnam
sever
diseas
combin
rapid
spread
along
intern
airtravel
rout
prompt
set
network
scientist
laboratori
around
world
tri
identifi
causal
agent
develop
diagnost
test
network
unit
laboratori
differ
method
capac
rapidli
fulfil
postul
establish
viru
caus
diseas
result
share
real
time
via
secur
websit
microscopi
pictur
protocol
test
pcr
primer
sequenc
also
post
find
discuss
daili
teleconfer
progress
facilit
share
laboratori
sampl
test
materi
network
identifi
new
coronaviru
consist
detect
sampl
sar
patient
sever
countri
conclus
name
caus
agent
sar
strain
unlik
known
member
genu
coronaviru
three
diagnost
test
avail
limit
march
day
issu
emerg
travel
advic
respons
sar
set
network
scientist
lead
laboratori
around
world
expedit
identif
caus
agent
sar
rapidli
develop
robust
reliabl
diagnost
test
network
model
partli
global
influenza
network
howev
urgenc
increasingli
seen
publichealth
emerg
call
rapid
adapt
meet
uniqu
need
ensur
virtual
collabor
laboratori
approach
telephon
throughout
weekend
march
object
secur
particip
laboratori
outstand
experi
detect
wide
rang
virus
microorgan
histori
collabor
intern
investig
coordin
access
sar
sampl
capac
fulfil
six
criteria
koch
postul
requir
establish
viru
caus
diseas
laboratori
ask
join
agre
work
accord
set
rule
confidenti
data
rule
specifi
data
inform
share
among
member
research
project
would
use
advanc
project
collabor
way
specif
scientif
data
could
share
outsid
network
approv
laboratori
data
inform
origin
avoid
discrep
offici
nation
case
notif
laboratori
inform
data
case
sampl
treat
separ
epidemiolog
inform
open
share
among
academ
competitor
requir
trust
willing
work
togeth
collabor
continu
daili
teleconfer
use
secur
websit
post
electron
microscopi
pictur
candid
virus
protocol
test
phylogenet
tree
pcr
primer
sequenc
result
variou
diagnost
test
arrang
allow
simultan
analys
sampl
patient
sever
laboratori
differ
approach
realtim
share
result
laboratori
area
sar
case
includ
canada
germani
franc
hong
kong
uk
usa
singapor
regularli
exchang
sampl
despatch
materi
laboratori
netherland
japan
initi
spare
sar
case
earli
april
laboratori
beij
guangdong
provinc
china
join
network
march
network
laboratori
report
avail
sampl
review
past
plan
intervent
strategi
catalogu
avail
laboratori
experi
capac
initi
bacteri
viral
rickettsia
chlamydia
pathogen
primarili
associ
respiratori
diseas
pathogen
respiratori
symptom
might
secondari
target
detect
method
use
includ
light
electron
microscopi
immunohistochemistri
anim
inocul
bacteri
cellcultur
isol
techniqu
serolog
pcr
analys
march
particip
laboratori
germani
report
paramyxoviru
singaporean
origin
electron
microscopi
isol
respiratori
sampl
sar
patient
frankfurt
directli
link
singapor
index
case
simultan
chines
univers
hong
kong
share
equivoc
result
gener
specif
human
metapneumoviru
pcr
primer
sampl
patient
develop
sar
contact
hong
kong
index
case
pcr
primer
test
three
addit
patient
find
posit
human
metapneumoviru
sequenc
primer
share
electron
network
secur
websit
next
day
singapor
laboratori
note
pleiomorph
viru
electron
microscopi
respiratori
sampl
sar
patient
rotterdam
laboratori
human
metapneumoviru
first
discov
sent
car
frankfurt
overnight
obtain
sampl
sar
patient
japanes
laboratori
report
neg
result
pcr
bronchoalveolar
lavag
serum
antibodi
obtain
index
case
hanoi
laboratori
found
evid
influenza
b
virus
respiratori
syncyti
viru
parainfluenza
virus
human
metapneumoviru
nipah
viru
hendra
viru
hanta
viru
lassa
ebola
marburg
crimeancongo
haemorrhag
fever
virus
march
human
metapneumoviru
primer
test
four
addit
laboratori
chines
univers
hong
kong
found
paramyxoviruslik
particl
respiratori
sampl
rotterdam
laboratori
detect
human
metapneumoviru
sampl
frankfurt
rotterdam
laboratori
sent
test
kit
human
metapneumoviru
singapor
hong
kong
laboratori
share
via
websit
phylogenet
tree
isol
paramyxoviru
laboratori
canada
ship
convalesc
sera
rotterdam
test
isol
daili
confer
call
singapor
laboratori
report
round
pleomorph
structur
sampl
scientist
germani
hong
kong
describ
similar
find
march
teleconfer
laboratori
rotterdam
establish
respiratori
sampl
cluster
test
germani
singapor
patient
neg
human
metapneumoviru
pcr
laboratori
also
isol
agent
caus
cytopathogen
effect
vero
monkey
kidney
cell
line
laboratori
uk
also
detect
influenza
viru
two
suspect
sar
case
laboratori
canada
detect
human
metapneumoviru
pcr
sampl
two
patient
provid
electronmicroscopi
pictur
small
viru
particl
around
nm
seen
bronchoalveolar
lavag
time
german
laboratori
isol
agent
vero
cell
murin
cell
line
laboratori
also
rule
presenc
respiratori
pathogen
influenza
b
virus
respiratori
syncyti
viru
parainfluenza
virus
type
adenoviru
rhinoviru
enteroviru
human
metapneumoviru
mycoplasma
pneumonia
chlamydia
pneumonia
later
day
scientist
hong
kong
univers
sent
email
indic
isol
agent
two
patient
sar
agent
isol
continu
rhesu
monkey
kidney
cell
produc
cytopathogen
effect
indic
growth
viru
addit
immunofluoresc
assay
virusinfect
cell
done
blind
trial
sera
sar
patient
rise
antibodi
titr
new
viru
isol
contrast
sera
blood
donor
taken
long
diseas
emerg
hong
kong
antibodi
viru
furthermor
viruslik
particl
cytoplasm
cell
membran
seen
thin
electron
microscop
section
infect
cell
find
prove
turn
point
search
sar
caus
agent
march
laboratori
usa
isol
viru
caus
cytopathogen
effect
vero
cell
patient
thailand
show
presenc
coronaviruslik
particl
electron
microscopi
size
nm
sampl
patient
us
laboratori
found
posit
pcr
signal
primer
picornaviru
later
identifi
rhinoviru
govern
viru
unit
hong
kong
us
laboratori
sent
electron
microscopi
pictur
coronaviruslik
particl
post
websit
simoultan
laboratori
canada
pari
chines
univers
detect
paramyxoviru
human
metapneumoviru
electron
microscopi
pcr
variou
sampl
singapor
laboratori
detect
human
metapneumoviru
test
kit
suppli
rotterdam
scientist
govern
viru
unit
hong
kong
provid
laboratori
usa
convalesc
sera
laboratori
canada
found
particl
nm
size
electron
microscopi
post
phylogenet
tree
human
metapneumoviru
sequenc
secur
websit
march
laboratori
usa
confirm
classif
coronaviru
base
coronaviruslik
sequenc
pcramplifi
product
post
initi
primer
amplif
websit
govern
viru
unit
hong
kong
test
inhous
coronaviru
primer
found
coronaviru
rna
two
eight
sampl
usa
laboratori
report
presenc
coronaviru
postmortem
kidney
sampl
hong
kong
also
develop
immunofluoresc
assay
detect
seroconvers
trial
nonhuman
primat
start
intratrach
infect
nasopharyng
swab
taken
singapor
hong
kong
laboratori
pari
canada
found
coronaviru
respiratori
sampl
electron
microscopi
pcr
respect
suckl
mice
hamster
inocul
day
previous
pasteur
unit
lyon
sampl
frankfurt
hanoi
describ
still
healthi
remain
laboratori
germani
japan
singapor
isol
cytopathogeniceffectcaus
agent
vero
cell
laboratori
uk
detect
specif
pcr
four
pneumoviru
sequenc
respiratori
sampl
probabl
suspect
case
consist
human
metapneumoviru
march
coronaviru
detect
pcr
electron
microscopi
laboratori
laboratori
germani
hong
kong
develop
share
refin
primer
detect
new
coronaviru
german
laboratori
pcr
product
sequenc
two
match
protein
level
polymeras
gene
known
coronavirus
sever
laboratori
report
coronaviru
particl
electron
microscopi
respiratori
sampl
faec
sequenc
new
coronaviru
began
laboratori
germani
rotterdam
hong
kong
german
laboratori
hong
kong
univers
laboratori
post
websit
first
phylogenet
tree
group
collect
discov
new
coronaviru
march
hong
kong
univers
made
avail
viru
isol
member
network
monkey
trial
continu
first
coronaviru
isol
obtain
hong
kong
univers
us
laboratori
report
neg
result
antibodi
new
coronaviru
larg
number
blooddonor
serum
sampl
viru
antibodi
rna
pcr
howev
consist
detect
increas
number
sar
patient
mani
network
laboratori
laboratori
japan
receiv
sampl
singapor
hong
kong
identifi
new
coronaviru
also
confirm
seroconvers
also
develop
pcr
primer
immunofluoresc
assay
system
igm
hong
kong
univers
report
pair
sera
patient
clinic
typic
sar
show
rise
titr
antibodi
new
coronaviru
detect
rna
faec
five
ten
sar
patient
govern
viru
unit
hong
kong
report
consist
posit
pcr
new
coronaviru
faec
sar
patient
day
onset
clinic
sign
laboratori
germani
found
rna
new
coronaviru
conjunctiv
liquid
one
patient
day
onset
clinic
symptom
human
metapneumoviru
continu
detect
sampl
sar
case
variou
countri
suggest
sar
might
caus
coinfect
two
virus
coronavirusprim
use
variou
laboratori
result
increas
number
posit
sampl
parallel
human
metapneumoviru
isol
found
pcr
variou
sampl
patient
canada
april
netherland
laboratori
monkey
infect
new
coronaviru
human
metapneumoviru
bothfirst
coronaviru
follow
metapneumoviru
anim
infect
coronaviru
alon
develop
fullblown
diseas
anim
infect
human
metapneumoviru
develop
mild
rhiniti
monkey
infect
coronaviru
metapneumoviru
develop
seriou
diseas
monkey
infect
metapneumoviru
alon
basi
find
network
scientist
collect
agre
coronaviru
alon
caus
symptom
sar
seen
human
be
howev
coinfect
agent
includ
chlamydia
human
metapneumoviru
could
result
sever
clinic
cours
elisa
test
develop
laboratori
usa
detect
antibodi
day
onset
clinic
sign
hong
kong
univers
laboratori
report
indirect
fluoresc
detect
antibodi
igm
day
addit
mice
hamster
infect
trial
start
pasteur
unit
lyon
invitro
ribavirin
efficaci
trial
began
rotterdam
germani
laboratori
japan
began
human
interferon
efficaci
trial
chines
laboratori
beij
continu
report
chlamydia
postmortem
sampl
sar
patient
april
month
network
began
function
particip
laboratori
collect
announc
conclus
identif
new
coronaviru
caus
agent
sar
announc
made
base
result
monkey
studi
done
netherland
laboratori
viru
found
mani
sar
patient
sever
countri
viru
caus
cytopathogen
effect
two
cell
line
vero
cell
fetal
rhesu
kidney
cell
electron
microscopi
cell
cultur
respiratori
sampl
sar
patient
show
coronaviruslik
particl
immunofluoresc
assay
serum
convalesc
patient
detect
cell
infect
viru
cell
cultur
reactiv
new
coronaviru
could
detect
serum
sever
hundr
nonsar
individu
usa
canada
hong
kong
gener
coronaviru
primer
detect
new
coronaviru
rna
cell
cultur
sampl
sar
patient
specif
primer
develop
sever
laboratori
current
compar
sensit
hyperimmun
sera
transmiss
gastroenter
viru
felin
infecti
periton
viru
human
coronaviru
react
viru
antigen
cell
cultur
partial
sequenc
new
coronaviru
sever
laboratori
confirm
affili
genu
coronaviru
shown
dissimilar
known
member
belong
three
exist
group
genu
three
diagnost
test
avail
limit
sinc
elisa
detect
antibodi
reliabl
day
onset
clinic
symptom
use
detect
case
potenti
spread
infect
other
second
test
immunofluoresc
assay
detect
antibodi
reliabl
day
infect
variou
version
realtim
blockbas
pcr
test
current
develop
improv
low
sensit
reduc
number
falseneg
test
result
exist
test
use
individu
combin
confirm
diseas
suspect
probabl
sar
case
work
need
reliabl
easytous
sensit
test
becom
avail
countri
work
toward
object
continu
proceed
rapid
pace
laboratori
contribut
substanti
rapid
identif
characteris
new
coronaviru
associ
sar
